Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 34
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 1651 | SIGMA COMPUTING | 9 | 111.1% | 8 | 0 | 2021–2022 |
| 1652 | SINTX TECHNOLOGIES | 9 | 111.1% | 7 | 1 | 2022–2023 |
| 1653 | SIXRING | 9 | 00% | 0 | 9 | 2022–2025 |
| 1654 | SMITHS DETECTION GERMANY | 9 | 00% | 0 | 9 | 2022–2025 |
| 1655 | SOLAR FOODS | 9 | 00% | 0 | 9 | 2022–2023 |
| 1656 | SOLSTICE ADVANCED MATERIALS US | 9 | 00% | 0 | 9 | 2025–2026 |
| 1657 | SPARKCOGNITION | 9 | 111.1% | 3 | 5 | 2022–2024 |
| 1658 | ST PHARM | 9 | 222.2% | 0 | 7 | 2023–2026 |
| 1659 | ST UBLI ELECTRICAL CONNECTORS | 9 | 00% | 0 | 9 | 2022–2026 |
| 1660 | STERILE STATE | 9 | 111.1% | 0 | 8 | 2023–2026 |
| 1661 | STOKE THERAPEUTICS | 9 | 00% | 0 | 9 | 2022–2025 |
| 1662 | SUMITOMO HEAVY INDUSTRIES | 9 | 00% | 0 | 9 | 2023–2025 |
| 1663 | SUMITOMO METAL MINING | 9 | 00% | 0 | 9 | 2022–2025 |
| 1664 | SUNSHO PHARMACEUTICAL | 9 | 00% | 1 | 8 | 2022–2025 |
| 1665 | SYSTEMS PROTECTION GROUP US | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1666 | TCL ZHONGHUAN RENEWABLE ENERGY TECHNOLOGY | 9 | 00% | 0 | 9 | 2024–2025 |
| 1667 | TDK | 9 | 333.3% | 1 | 5 | 2022–2024 |
| 1668 | TECHNO UMG | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1669 | TENOVA | 9 | 00% | 2 | 7 | 2022–2026 |
| 1670 | TERAWATT TECHNOLOGY | 9 | 00% | 0 | 9 | 2025–2025 |
| 1671 | TEREX SOUTH DAKOTA | 9 | 00% | 0 | 9 | 2023–2026 |
| 1672 | THE AUTOMATION PARTNERSHIP CAMBRIDGE | 9 | 00% | 0 | 9 | 2022–2026 |
| 1673 | THK | 9 | 111.1% | 0 | 8 | 2022–2026 |
| 1674 | TREEFROG THERAPEUTICS | 9 | 00% | 0 | 9 | 2022–2025 |
| 1675 | USHIO DENKI | 9 | 111.1% | 2 | 6 | 2023–2025 |
| 1676 | VESUVIUS GROUP | 9 | 111.1% | 0 | 8 | 2021–2026 |
| 1677 | VGP IPCO | 9 | 333.3% | 0 | 6 | 2022–2025 |
| 1678 | WEIR MINERALS NETHERLANDS | 9 | 00% | 0 | 9 | 2024–2026 |
| 1679 | WUXI BIOLOGICS IRELAND | 9 | 00% | 0 | 9 | 2024–2026 |
| 1680 | WUXI HISKY MEDICAL TECHNOLOGIES | 9 | 888.9% | 1 | 0 | 2022–2024 |
| 1681 | YAMATO PROTEC | 9 | 333.3% | 0 | 6 | 2022–2023 |
| 1682 | ZHONGYE CHANGTIAN INTERNATIONAL ENGINEERING | 9 | 00% | 0 | 9 | 2024–2025 |
| 1683 | 4D MOLECULAR THERAPEUTICS | 8 | 00% | 0 | 8 | 2022–2025 |
| 1684 | ABIVAX | 8 | 337.5% | 1 | 4 | 2022–2024 |
| 1685 | ABL BIO | 8 | 00% | 0 | 8 | 2022–2026 |
| 1686 | ACCELERON PHARMA | 8 | 00% | 1 | 7 | 2022–2024 |
| 1687 | ACE TECHNOLOGIES | 8 | 112.5% | 0 | 7 | 2022–2025 |
| 1688 | ACO AHLMANN SE KG | 8 | 225% | 1 | 5 | 2022–2025 |
| 1689 | ACUCELA | 8 | 00% | 5 | 3 | 2022–2023 |
| 1690 | ADAPTIX | 8 | 00% | 7 | 1 | 2022–2024 |
| 1691 | ADIMAB | 8 | 00% | 0 | 8 | 2022–2025 |
| 1692 | AEROSTAR INTERNATIONAL | 8 | 112.5% | 2 | 5 | 2022–2023 |
| 1693 | AESC JIANGSU | 8 | 00% | 0 | 8 | 2025–2026 |
| 1694 | AESC SHANGHAI | 8 | 00% | 0 | 8 | 2025–2026 |
| 1695 | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH | 8 | 00% | 0 | 8 | 2022–2025 |
| 1696 | AGILENT TECHNOLOGIES | 8 | 00% | 1 | 7 | 2022–2024 |
| 1697 | AGIOS PHARMACEUTICALS | 8 | 112.5% | 1 | 6 | 2020–2026 |
| 1698 | AHLSTROM | 8 | 00% | 0 | 8 | 2023–2026 |
| 1699 | AIR HOLDINGS | 8 | 00% | 2 | 6 | 2022–2026 |
| 1700 | ALFDEX | 8 | 225% | 0 | 6 | 2022–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →